PND30 Cost Analysis of Glatiramer Acetate Versus Fingolimod for the Treatment of Patients With Relapsing-Remitting Multiple Sclerosis in Spain

Nov 1, 2012, 00:00
10.1016/j.jval.2012.08.1954
https://www.valueinhealthjournal.com/article/S1098-3015(12)03667-4/fulltext
Title : PND30 Cost Analysis of Glatiramer Acetate Versus Fingolimod for the Treatment of Patients With Relapsing-Remitting Multiple Sclerosis in Spain
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)03667-4&doi=10.1016/j.jval.2012.08.1954
First page : A551
Section Title : Neurological Disorders
Open access? : No
Section Order : 1441
Categories :
Tags :
Regions :
ViH Article Tags :